CLINICAL_TRIALS
research
· 2025-03-17
Clinical Trial Update: Study to Evaluate the Safety and Tolerability of FX201 in Patients with Osteoarthritis of the Knee [Phase 1]
Summary
A Phase 1 study evaluating the safety and tolerability of FX201 in patients with osteoarthritis of the knee is currently active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Osteoarthritis, Knee | Phase 1 | Status: ACTIVE_NOT_RECRUITING